Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancer
NCT03124615
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
47
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Enzalutamide
Sponsor
Macquarie University, Australia